Streetbeat News

Stock Prices

ACB

Aurora Cannabis has acquired the remaining approximately 90% equity interest in MedReleaf Australia for an enterprise value of AUD$50M, making it the largest global medical cannabis company in legal markets. MedReleaf Australia is ranked second in the Australian medical cannabis market, valued at around AUD$400 million. The transaction is anticipated to positively impact Aurora's Adjusted EBITDA immediately and hasten its path to generating positive free cash flow in 2024.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:55 am

KIM

Kimco Realty reported a Q4 pro-rata portfolio occupancy of 96.2%, marking a 70-basis-point sequential increase, the largest in over 15 years.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:55 am

LQDT

Liquidity Services (NASDAQ:LQDT) reported Q1 adjusted EPS of $0.14, missing the $0.15 estimate, and sales of $71.33M, below the $76.96M estimate. This represents a 26.32% decrease in EPS and a 1.32% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:54 am

KIM

Kimco Realty has provided its 2024 FFO (Funds From Operations) guidance, forecasting a range of $1.54-$1.58. This projection falls below the consensus expectations of $1.62.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:54 am

BKE

The Buckle, Inc. (BKE) reported a significant decline in comparable store net sales of 17.4% year-over-year for the 5-week period ended February 3, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:53 am

LSPD

Lightspeed Commerce (LSPD) reported Q3 adjusted earnings of $0.08 per share, surpassing the consensus estimate of $0.03 by 166.67%. Quarterly sales reached $239.69 million, exceeding estimates of $235.66 million by 1.71% and marking a 27.03% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:52 am

BN

Brookfield reported Q4 2023 adjusted EPS of $0.83, surpassing the $0.72 estimate, with sales rising to $24.52B from $24.21B YoY. Despite beating estimates, EPS decreased by 11.7% from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:49 am

TPR

Tapestry (NYSE:TPR) reported Q2 adjusted EPS of $1.63, surpassing the $1.46 estimate, marking an 11.64% beat and a 19.85% increase from last year's $1.36. Sales reached $2.08B, exceeding the $2.05B estimate by 1.71% and showing a 2.96% increase from the previous year's $2.02B.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:47 am

WMS

Advanced Drainage Systems (NYSE:WMS) reported Q3 adjusted EPS of $1.37, surpassing the $1.02 estimate, and sales of $662.37M, exceeding the $629.29M estimate. This represents a 38.38% increase in EPS and a 1.10% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:47 am

HSY

Hershey projects its net sales to grow between 2% to 4% in 2024, indicating a positive outlook for the company's financial performance.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:47 am